Hypertension and Nephrology

FIDELIO DKD Results

Investigator Gerasimos Filippatos, MD summarizes the results of FIDELIO-DKD, which examined whether finerenone affected cardiovascular outcomes in patients with chronic kidney disease and T2DM.

Science News

Inequities in Hypertension Control in the United States Exposed and Exacerbated by COVID‐19 and the Role of Home Blood Pressure and Virtual Health Care During and After the COVID‐19 Pandemic
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
Evaluation and Management of Aortic Stenosis in Chronic Kidney Disease
2020 AHA/ACC Consensus Conference on Professionalism and Ethics
First-Phase Ejection Fraction, a Measure of Preclinical Heart Failure, Is Strongly Associated With Increased Mortality in Patients With COVID-19

Journals

Thomas Willis Lecture: Targeting Brain Arterioles for Acute Stroke Treatment
Discontinuation of Antihypertensive Medications on the Outcome of Hospitalized Patients With Severe Acute Respiratory Syndrome-Coronavirus 2
Chronic Cardio‐Metabolic Disease Increases the Risk of Worse Outcomes Among Hospitalized Patients With COVID‐19: A Multicenter, Retrospective, and Real‐World Study
Occupational Physical Activity and New-Onset Hypertension: A Nationwide Cohort Study in China
Blood Pressure Determinants of Cerebral White Matter Hyperintensities and Microstructural Injury: UK Biobank Cohort Study

Continuing Education

Young male healthcare worker adjusts blood pressure cuff on the arm of an older male patient.

The Hypertension Council fosters excellence in hypertension research and education in support of the AHA’s mission. Hypertension remains a world-wide public-health challenge and is a leading cause of stroke, heart disease, and the progression of chronic kidney disease. The annual Hypertension Scientific Sessions showcases timely research.


The KCVD Council works to reduce cardiovascular-related disability and death through research, communication, advocacy, and education about the kidney. Kidney disease is a major cause and consequence of cardiovascular disease. Chronic renal insufficiency can contribute to development of hypertension, vascular disease, atherosclerosis and other morbidity and mortality risk factors.


American Heart Association Professional Members

Enjoy instant benefits!

  • Free Online Access to AHA Scientific Journals
  • Affiliate with our 16 Scientific Councils
  • Discounts on Scientific Conference Registration and Online Courses